Highly Efficient Delivery of Novel MiR-13896 by Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Inhibits Gastric Cancer Progression by Targeting ATG2A-Mediated Autophagy
2024

Using Stem Cells to Fight Stomach Cancer

publication 10 minutes Evidence: high

Author Information

Author(s): Wu Peipei, Wang Min, Jin Can, Li Linli, Tang Yuting, Wang Zhangfei, Wang Xianwen, Xu Wenrong, Qian Hui

Primary Institution: University of Science and Technology of China

Hypothesis

Can human umbilical cord stem cell-derived small extracellular vesicles effectively inhibit gastric cancer progression?

Conclusion

The study found that miR-13896 delivered by stem cell-derived vesicles significantly inhibits gastric cancer cell growth and promotes apoptosis.

Supporting Evidence

  • MiR-13896 was identified as a potent inhibitor of gastric cancer cell proliferation.
  • HucMSC-sEVs effectively delivered miR-13896 to target tumor sites.
  • Engineered hucMSC-sEVs significantly reduced gastric cancer cell growth and migration in vitro and in vivo.
  • Autophagy-related protein ATG2A was down-regulated by miR-13896, contributing to the inhibition of gastric cancer progression.

Takeaway

Scientists are using tiny bubbles from stem cells to deliver a special molecule that helps stop stomach cancer from growing.

Methodology

The study involved isolating stem cells from umbilical cords, creating small extracellular vesicles, and testing their effects on gastric cancer cells in vitro and in vivo.

Limitations

The study primarily focused on in vitro and animal models, which may not fully replicate human responses.

Participant Demographics

The study used umbilical cord tissue from newborns and gastric cancer cell lines.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.34133/bmr.0119

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication